Sharon Klahre | executive |
Michael Metzger | executive |
Neil Gallagher | executive |
Keith Goldan | executive |
Anupam Rama | analyst |
Philip Nadeau | analyst |
Bradley Canino | analyst |
Michael Schmidt | analyst |
Ashiq Mubarack | analyst |
Alexandria Hammond | analyst |
Kalpit Patel | analyst |
Jeet Mukherjee | analyst |
Anjali Ganguli | executive |
Good day, everyone, and welcome to the Syndax Fourth Quarter and Full Year 2023 Earnings Conference Call. Today's call is being recorded. [Operator Instructions]At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals.
Great. Thank you, operator.